Trial Search Results
Treatment of Schizoaffective Disorder Using Mifepristone
This study tests the hypothesis that mifepristone will diminish cognitive distortion and alleviate psychosis in patients with schizoaffective disorder.
Stanford is currently not accepting patients for this trial.
Collaborator: Pritzker Family Foundation
- Drug: Mifepristone
- Drug: Placebo Oral Tablet
Phase 2/Phase 3
Inclusion Criteria:The subjects will be 30 inpatients or outpatients with schizoaffective
disorder. Exclusion Criteria:Subjects must be between the ages of eighteen and seventy-five
without major medical problems.
Ages Eligible for Study
18 Years - 75 Years
Genders Eligible for Study